Greenpro Capital Corp.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The issuances described below were made in transactions not involving a public offering. In connection with the issuances, the Company relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and Regulation D and/or Regulation S promulgated thereunder, as applicable to each issuance. The securities were issued as restricted securities and are subject to applicable limitations on transfer.

Issuance of 8,500,000 shares on March 31, 2026

On March 31, 2026, the Company acquired a 13.6% equity interest of Forekast Limited, a company formed under the laws of the British Virgin Islands (“Forekast”) in exchange by issuance of 8,500,000 shares of its Common Stock to the shareholders of Forekast Limited (the “Forekast Shareholders”), valued at $17,000,000 to the Forekast Shareholders.

Issuance of 800,000 shares on April 16, 2026

On April 16, 2026, the Company acquired 0.99% shareholdings of Greenophene Technologies Limited, a company incorporated in the British Virgin Islands (“Greenophene”) from Lim Chee Yin, a shareholder of Greenophene (the “Seller”) in exchange by issuance of 800,000 shares of the Company’s Common Stock to the Seller, valued at $1.50 per share or an aggregate value of $1,200,000.

Issuance of 201,850 shares from April 28 to June 30, 2026

From April 28 to June 30, 2026, the Company sold and issued in aggregate 201,850 shares of its Common Stock to its Chief Executive Officer, President and Director, Mr. Lee, Chong Kuang (“Mr. Lee”) in private placements at total cash proceeds of $400,000. The Company plans to use the proceeds for operating capital.

A list of the issuance of the Company’s Common Stock during the six months ended June 30, 2026, is set forth below: